Skip to content

Clinical trials

Observational Cholangiocarcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Observational Country / region: China Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20131
20173
20182
20191
20204
20211
20223
20233
202412
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status18
Recruiting8
Completed5
Not yet recruiting2
Withdrawn1
Enrolling by invitation1
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University4
First Affiliated Hospital, Sun Yat-Sen University3
Peking Union Medical College Hospital3
Qilu Hospital of Shandong University2
Shanghai Zhongshan Hospital2
Sun Yat-sen University2
Beijing Friendship Hospital1
Beijing Tsinghua Chang Gung Hospital1
Fudan University1
Fujian Provincial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma37
Carcinoma, Hepatocellular8
Gallbladder Neoplasms7
Liver Neoplasms6
Biliary Tract Neoplasms5
Pancreatic Neoplasms5
Stomach Neoplasms4
Breast Neoplasms3
Colorectal Neoplasms3
Klatskin Tumor3

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.